Key result
Slowly adhering cardiac mesenchymal cells improve LVEF by ~7% versus vehicle in mice post-MI.
Authors
Loading...
Experimental study demonstrates myocardial reparative capacity of adherence-isolated cardiac mesenchymal cells, indicating potential for targeted cardiac cell therapy.
Absolute Event Rate: 31.2% vs 24.7%
p-value: p=< 0.05
Wysoczynski et al. (2017) studied Myocardial infarction. Slowly adhering (SA) cardiac mesenchymal cells (CMCs) vs. Vehicle and rapidly adhering (RA) CMCs was evaluated on Left ventricular ejection fraction at 28 days (p=< 0.05). In mice subjected to myocardial infarction, treatment with slowly adhering cardiac mesenchymal cells significantly increased left ventricular ejection fraction at 28 days compared to vehicle (31.2% vs 24.7%; p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: